-
-
-
The ED physician and trauma surgeon must have evidence-based
information on indications for emergency department thoracotomy that
can be determined rapidly, easily accessible equipment, and the ability
to recognize situations in which EDT clearly is not in the patients
best interest.
-
Drs. Gregg Stone and Stephen Ellis presented the 9-month clinical and angiographic results from TAXUS IV, which was designed to assess the safety and efficacy of the TAXUS slow-release polymer-based paclitaxel-eluting Express2 stent (Boston Scientific) in a broad cross-section of patients.
-
Sertraline contributed to a decrease in platelet activation over and above either aspirin or thienopyridines, and the SSRI might represent an attractive additional advantage for patients with depression and comorbid coronary artery disease and stroke.
-
-
The 3 CHARM studies (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) and their combined results were presented at the ESC meeting and published in Lancet in September.
-
The European Trial of Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) study tested the hypothesis that perindopril in patients with stable coronary artery disease, but without heart failure or substantial hypertension, will reduce cardiovascular deaths, myocardial infarction, and cardiac arrest.
-
The intracoronary stenting with antithrombotic Regimen Cooling Off (ISAR-COOL) study results were initially presented at the 2002 American
Heart Association Scientific Session.
-
Hylek and colleagues report on the effects of varying intensities of oral anticoagulation on the frequency and severity of strokes among patients with atrial fibrillation.
